Ryan Park Selected Research

Arabinofuranosyluracil (Ara U)

1/2017	Effect of Androgen on Normal Biodistribution of [18F]-2'-Fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (18F-FMAU) in Athymic Non-tumor-bearing Male Mice.
9/2012	[18F]-2'-Fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (18F-FMAU) in prostate cancer: initial preclinical observations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ryan Park Research Topics

Disease

38	Neoplasms (Cancer) 01/2021 - 01/2004
5	Brain Neoplasms (Brain Tumor) 01/2006 - 01/2004
4	Prostatic Neoplasms (Prostate Cancer) 11/2019 - 08/2004
4	Glioblastoma (Glioblastoma Multiforme) 04/2012 - 01/2006
3	Carcinogenesis 01/2021 - 09/2006
3	Breast Neoplasms (Breast Cancer) 07/2013 - 01/2004
3	Traumatic Brain Injuries (Traumatic Brain Injury) 07/2012 - 01/2009
3	Neoplasm Metastasis (Metastasis) 01/2011 - 01/2004
2	Lung Neoplasms (Lung Cancer) 01/2021 - 03/2005
2	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 09/2006
2	Glioma (Gliomas) 04/2012 - 02/2004
2	Hypoxia (Hypoxemia) 02/2012 - 01/2009
2	Brain Hypoxia (Cerebral Hypoxia) 02/2010 - 01/2009
2	Adenocarcinoma 08/2007 - 08/2004
1	Diffuse Scleroderma (Progressive Systemic Sclerosis) 02/2022
1	Systemic Scleroderma (Systemic Sclerosis) 02/2022
1	Adenoma (Adenomas) 01/2021
1	Colitis-Associated Neoplasms 01/2019
1	Colitis 01/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2015
1	Necrosis 12/2013
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2013
1	Brain Edema (Cerebral Edema) 02/2010
1	Liver Diseases (Liver Disease) 08/2009
1	Liver Neoplasms (Liver Cancer) 08/2009
1	Hepatocellular Carcinoma (Hepatoma) 08/2009
1	Hyperplasia 08/2007

Drug/Important Bio-Agent (IBA)

10	Peptides (Polypeptides)IBA 11/2019 - 01/2004
10	arginyl-glycyl-aspartic acidIBA 09/2011 - 01/2004
7	IntegrinsIBA 01/2011 - 01/2004
6	Integrin alphaVIBA 01/2006 - 01/2004
5	cyclic arginine-glycine-aspartic acid peptideIBA 11/2019 - 01/2004
5	AndrogensIBA 01/2017 - 08/2004
5	Cell Adhesion MoleculesIBA 03/2005 - 01/2004
5	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 03/2005 - 01/2004
4	Integrin alphaVbeta3IBA 09/2004 - 01/2004
3	AntibodiesIBA 12/2013 - 07/2012
3	LigandsIBA 04/2012 - 03/2005
2	Arabinofuranosyluracil (Ara U)IBA 01/2017 - 09/2012
2	Biomarkers (Surrogate Marker)IBA 07/2015 - 01/2013
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 08/2014 - 12/2013
2	CY5.5 cyanine dyeIBA 08/2014 - 12/2013
2	EphB4 ReceptorIBA 07/2013 - 01/2013
2	Glucose (Dextrose)FDA LinkGeneric 07/2012 - 04/2005
2	AcidsIBA 02/2012 - 10/2004
2	Propranolol (Inderal)FDA LinkGeneric 02/2010 - 01/2009
2	polypeptide CIBA 08/2004 - 01/2004
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 02/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 02/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2022
1	Methotrexate (Mexate)FDA LinkGeneric 02/2022
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2021
1	DisintegrinsIBA 11/2019
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	AntigensIBA 01/2019
1	AzoxymethaneIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Dextran SulfateIBA 01/2019
1	B7-H1 AntigenIBA 01/2019
1	Coloring Agents (Dyes)IBA 08/2014
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2013
1	Vinblastine (Vinblastine Sulfate)FDA Link 12/2013
1	Fluorouracil (Carac)FDA LinkGeneric 12/2013
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2013
1	Etoposide (VP 16)FDA LinkGeneric 12/2013
1	EphrinsIBA 07/2013
1	Contrast MediaIBA 01/2013
1	CD13 Antigens (Alanine Aminopeptidase)IBA 01/2013
1	NGR peptideIBA 01/2013
1	Androgen Receptors (Androgen Receptor)IBA 09/2012
1	ThymidineIBA 09/2012
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 07/2012
1	Adrenergic Receptors (Adrenergic Receptor)IBA 07/2012
1	CytokinesIBA 07/2012
1	Molecular Probes (Molecular Probe)IBA 04/2012
1	64Cu-AmBaSar-RGD2IBA 01/2011
1	MethyltransferasesIBA 08/2009
1	S-Adenosylmethionine (Ademetionine)IBA 08/2009
1	LectinsIBA 01/2009
1	Ricinus communis agglutinin-1IBA 01/2009
1	enhanced green fluorescent proteinIBA 08/2007
1	LuciferasesIBA 08/2007
1	2'-fluoro-5-ethylarabinosyluracil (FEAU)IBA 06/2007
1	fialuridineIBA 06/2007
1	Transforming Growth Factor beta (TGF-beta)IBA 09/2006

Therapy/Procedure

11	Therapeutics 01/2019 - 01/2004
1	Radiotherapy 12/2013
1	Immunotherapy 12/2013
1	Drug Therapy (Chemotherapy) 12/2013
1	Islets of Langerhans Transplantation 02/2013
1	Computer-Assisted Surgery (Image Guided Surgery) 12/2012
1	Precision Medicine 01/2011
1	Chemoprevention 08/2009
1	Castration 08/2007